Artificial Intelligence
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
An analysis of how trial designs focused on immune response metrics bypass FDA requirements, potentially delaying approvals for lifesaving cancer combinations.
-
Claude’s New Personal Finance Tool Lets Users Spot Spending Leaks via Chat
Anthropic’s new feature connects to bank accounts via Plaid, allowing users to ask conversational questions to categorize spending and flag duplicate charges.
-
AI Paper Mills Flood Journals With Unverifiable Health Studies, Researchers Warn
Chinese software generates publishable papers in under two hours using public data, but withholds code needed for verification, overwhelming peer review.
-
Major study links moderate alcohol consumption to increased cancer risk and early death
Even one drink a day raises risk of cancer, heart disease and premature death, researchers say, challenging the idea that moderate drinking…
-
Stanford Digital Twins Point to a Drug Pair That May Delay Preterm Labor
Researchers use immune system simulations to find a drug pair that delays labor 15 times better than aspirin alone, offering hope for…
-
Epigenetic Clocks: Measuring Biological Age and Predicting Mortality
LONDON, July 8 — The biological clock may be more than a metaphor. For over a decade, researchers have been building tools…
-
How our AI Research team uses AI Runtime
SAN FRANCISCO, October 16 — Databricks’ AI Research team shared how they use the company’s own AI Runtime to power their model…
-
Google Overhauls AI Studio With a Build Tool for One-Click App Deployment
Mountain View, October 15 — Google has announced a significant update to its Google Play platform, aimed at simplifying the process for…
-
Air Liquide Invests €170 Million to Support Japanese Semiconductor Manufacturer’s Expansion
TOKYO, September 30 — Air Liquide, the French multinational gas company, has announced a €170 million investment to supply ultra-high purity gases…
-
Blue Cross Blue Shield Association Ties Hospital AI Coding Tools to $942 Million in Added Costs
BERKELEY, September 27 — Artificial intelligence tools used in medical billing and claims processing pushed patient costs up by nearly $1 billion…
-
Altman and Musk Back Amodei’s Call to Pace AI Development as Trump Pushes Back
San Francisco, September 18 — The fight over how fast artificial intelligence should move has turned inward, and the industry is splitting…
-
Financial planner urges against AI money reviews: protect your patience
New Delhi, August 22 — Henry Thomas visited a financial planning office in the city to understand how artificial intelligence is reshaping…
-
Germany Investigates Suspected Russian Weapons Cache Found in Woods Near Berlin
Berlin, August 21 — The discovery of a Russian-linked gun stash in a forest near Berlin last year has sent ripples through…
-
NYU AI Test Edges Out Oncotype DX in Predicting Breast Cancer Recurrence
NEW YORK, July 12 — A new AI tool from New York University may offer a cheaper alternative to genomic tests for…
-
Eric Topol’s four-decade journey reshaping medicine with digital innovation
LA JOLLA — Eric Topol has spent the better part of four decades pulling medicine into the digital age, and he has…
-
Motley Fool Columnist Predicts AI Stock Bubble Will Burst, Citing Four Warning Signs
WASHINGTON, July 6 — A new Treasury Department report is warning that the artificial intelligence stock frenzy could end badly for everyday…
-
Personalized Vaccine Plus Immunotherapy Shows Promise in Advanced Head and Neck Cancer
NEW YORK, July 5, 2026 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope. The…
-
Expert warns of tax risks in using pre-IPO AI stock for home purchases
San Jose State University tech expert Ahmed Banafa has a warning for anyone tempted to swap pre-IPO shares for a house: the…
-
Nutraceutical formula shows potential in cancer treatment study
ISLAMABAD, July 1 — A new study has turned to an unexpected source in the fight against cancer: a nutraceutical formula called…
-
Why Medical Deepfakes Are a Public Health Risk
WASHINGTON, June 25 — The rise of generative artificial intelligence has made it “really easy” to create convincing medical deepfakes, posing a…
-
AI-designed vaccine passes first human trial, targets multiple coronaviruses
/ HTML. So we can have headings and paragraphs . Must not add new info. Must keep facts: AI-designed vaccine from University…
-
AI-Designed Universal Coronavirus Vaccine Passes First Human Trial
SOUTHAMPTON, June 5 — Researchers at the University of Cambridge and their spinout DIOSynVax have completed the first human trial of a…
-
Paris AI Summit Declaration Signed by 60 Countries as US and UK Decline
The Artificial Intelligence Action Summit, co-chaired by French President Emmanuel Macron and Indian Prime Minister Narendra Modi, drew to a close yesterday…
-
Stability AI Releases Stable Diffusion 3 Medium With Improved Text Rendering
On June 12, Stability AI dropped Stable Diffusion 3. The upgrade is a direct shot at better image quality and, crucially, cleaner…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























